Pentazocine With Rectal Diclofenac Versus Pentazocine Alone for Pain Relief Following Caesarean Delivery: A Randomised Controlled Trial
Not Applicable
- Conditions
- Caesarean Delivery
- Registration Number
- PACTR202107706925314
- Lead Sponsor
- Ofor Ifeanyichukwu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
All consenting women with lower segment caesarean delivery under spinal anaesthesia
Women with term gestations (37-42 weeks)
Women with singleton pregnancy
Exclusion Criteria
Women with known history of peptic ulcer disease
Women with allergies to NSAIDs and pentazocine
Sickle cell disease patients
Asthmatic patients
Patients who had still births
Patients with opiod dependency
Obese women
Patients who had still births
Patients with morbidities that may affect pain management
Patients who may have complicated and prolonged surgeries (lasting over 90 minutes)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The level of pain perception measured using the VAS for pain.
- Secondary Outcome Measures
Name Time Method evel of satisfaction with pain relief, ;Need for breakthrough analgesia;Maternal side effects;Time of onset of bowel movement;Time of onset of ambulation